![logo](/logos/AMRX.webp)
Amneal Pharmaceuticals, Inc.
NYSE:AMRX
8.39 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Amneal Pharmaceuticals, Inc. |
Symbool | AMRX |
Munteenheid | USD |
Prijs | 8.39 |
Beurswaarde | 2,597,065,837 |
Dividendpercentage | 0% |
52-weken bereik | 3.36 - 8.72 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Chirag K. Patel |
Website | https://www.amneal.com |
An error occurred while fetching data.
Over Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)